MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202511123702 A) filed by Indian Institute Of Technology Kanpur on December 08, 2025, for Nanoparticulate Formulation Of Remdesivir And Doxorubicin And Method Of Preparing The Same.
Inventors include Katti, Dhirendra S.; Bose, Adrija; and Zaidi, Zahra Sifat.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present disclosure relates to multi-agent pharmaceutical compositions comprising Remdesivir in combination with chemotherapeutic small molecules such as Doxorubicin, and to nanoparticle-based systems for their delivery. The composition employs carboxylated chitosan–coated mesoporous silica nan...